Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.

While other big pharmas have faltered, Lilly made headway in a Phase 3 trial that could provide a treatment option to replace ...

By far, the largest acquisition of 2024 was Novo Holdings' yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion.

A Boulder-based company that is developing a orally-delivered drug for obesity and metabolic disorders just reached $25M in ...

The FDA has accepted the NDA for paltusotine for the treatment and long-term maintenance of acromegaly in adults.

It looks like Eli Lilly’s oral selective estrogen receptor degrader (SERD) imlunestrant may need some extra help to reach a ...

Hopes of a bright new future in stroke risk management in AF were dashed when asundexian failed against apixaban in the ...

A fixed duration combination of venetoclax with acalabrutinib, with or without obinutuzumab, was superior to standard ...

The Pharmacy and Poisons Board (PPB) has ordered the quarantine of pain killer drug Mefnac oral (Mefenamic Acid 50 Mg/5 MI).

Cadence OTC sells an affordable morning after pill in convenience stores. The company is also working to make a birth control ...

ISM5411 is designed to directly regulate the intestinal immune microenvironment so that the drug simultaneously reduces the gut inflammation seen in IBD while also promoting the repair of the ...

The company will develop a pipeline of small molecule inhibitors that target a unique lipid-binding pocket on proteins.